Innovative Therapies

Globally, diabetes affects over 463 million adults, with type 2 diabetes accounting for about 90% of cases. New therapies like SGLT2 inhibitors and GLP-1 receptor agonists have shown promise in managing blood glucose and weight. For example, SGLT2 inhibitors have been associated with a 30% reduction in hospitalization for heart failure. Continued research into beta-cell regeneration and immunotherapy could offer hope for future breakthroughs.

    Related Conference of Innovative Therapies

    September 08-09, 2025

    24th World Congress on Nutrition and Food Chemistry

    Frankfurt, Germany
    September 15-16, 2025

    29th World Congress on Nutrition and Food Sciences

    Paris, France
    November 13-14, 2025

    18th World Congress on Food Chemistry and Food Microbiology

    Bali, Indonesia
    December 08-09, 2025

    8th World Congress on Food and Nutrition

    Rome, Italy
    January 29-30, 2026

    30th International Conference on Nutritional Science & Dietetics

    Chicago, USA
    February 16-17, 2026

    32nd International Conference on Clinical Nutrition

    Aix-en-Provence, France
    March 19-20, 2026

    25th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders

    Paris, France
    March 26-27, 2026

    9th World Congress on Nutrition and Obesity Prevention

    Tokyo, Japan
    April 02-03, 2026

    31st International Conference on Nutrition & Dietetics

    Geneva, Switzerland
    April 13-14, 2026

    9th International Conference on Womens Health and Fitness

    Tokyo, Japan
    April 23-24, 2026

    8th World Summit on Health Nutrition

    Paris, France
    May 18-19, 2026

    9th International Conference on Food Safety and Health

    London, UK
    August 24-25, 2026

    25th International Congress on Nutrition and Health

    Aix-en-Provence, France

    Innovative Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in